Patent foramen ovale-related complications in left ventricular assist device patients: a reappraisal for cardiovascular professionals.
Daniela BacichAndrea FiorencisGabriele BraggionMarco ZuinGianluca RigatelliPublished in: Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs (2019)
Left ventricular assist device (LVAD) implantation is an important treatment option for patients with advanced heart failure. The presence of a patent foramen ovale (PFO) may elicit undesired consequences in LVAD patients: hypoxemia and paradoxical embolization. The variable physiological status of the patient with heart failure can make pre-LVAD implant identification of a PFO elusive. When identified pre- or intraoperatively, PFO is closed at time of LVAD implantation. In the case of delayed diagnosis, percutaneous PFO closure has proven to be a feasible and safe solution. As mechanical circulatory support gains prevalence, it is important to raise awareness of physiological implications of right-to-left shunt during mechanical circulatory support. We reviewed the diagnostic and therapeutic management of PFO in LVAD patients.